Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: DL never needed to "agree" to the 3rd party. That is an excuse for Carl

The JV agreement has the mechanics for what happens when parties cannot agree on such matters, this is a common provision spelled out in Contracts of all sorts.

We all know it's highly suspicious that Carl didn't institute the Arbitration process for the 3rd Seat since DL's Senior Vice President vacated it almost 5 years ago. Why now ? Is it only because the Creditor's Committee will likely replace DL on PDS ?

Was Carl protecting the status quo ? It sure seems like it to me, even though the composition was benefiting DL at the expense of PTSC. Carl didn't even require the Seat filled as part of the Settlement in 2012, so what's his motivation now besides appearing as if he's protecting the company's interests.

Nope... seems clear to me

More outside lawyers eyes ..

More Court revelations & exposures ..

More attention and outsiders involved in PDS ..

Concerns that Shareholders may be lawyering up ..

and a SHAM in 30 days ..

Share
New Message
Please login to post a reply